Award recordCONTRACT

CARTER BLOODCARE

PIID 36C25718C0088· VHA· 257-NETWORK CONTRACT OFFICE 17 (36C257)· 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES· FY2018· $1,340,468 net obligations· UEI RFL7D3RDNTN3· TX

Description

BLOOD PRODUCTS FOR CENTRAL TEXAS

Base award description: IGF::OT::IGF BLOOD PRODUCTS

First action · last action
2018-03-23 · 2023-06-07
Transactions
11
First transaction's obligation
$369,453
Base + all options value (sum of deltas)
$1,340,468
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
621991 · BLOOD AND ORGAN BANKS

Modification chain · 11 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$1,622,172$0Base award · 2018-03-23 · this action $369,453 · running total $369,453Modification P00001 · 2019-02-20 · this action $366,935 · running total $736,388Modification P00002 · 2019-08-09 · this action -$66,521 · running total $669,867Modification P00003 · 2020-03-30 · this action $390,553 · running total $1,060,420Modification P00004 · 2020-09-28 · this action -$88,518 · running total $971,902Modification P00005 · 2021-01-25 · this action $390,553 · running total $1,362,455Modification P00006 · 2021-10-01 · this action -$130,836 · running total $1,231,619Modification P00007 · 2022-01-04 · this action $390,553 · running total $1,622,172Modification P00008 · 2022-01-26 · this action -$2,478 · running total $1,619,694Modification P00009 · 2022-09-22 · this action -$92,144 · running total $1,527,550Modification P00010 · 2023-06-07 · this action -$187,083 · running total $1,340,468
  • Base2018-03-23+$369,453= $369,453
  • Mod P000012019-02-20+$366,935= $736,388
  • Mod P000022019-08-09-$66,521= $669,867
  • Mod P000032020-03-30+$390,553= $1,060,420
  • Mod P000042020-09-28-$88,518= $971,902
  • Mod P000052021-01-25+$390,553= $1,362,455
  • Mod P000062021-10-01-$130,836= $1,231,619
  • Mod P000072022-01-04+$390,553= $1,622,172
  • Mod P000082022-01-26-$2,478= $1,619,694
  • Mod P000092022-09-22-$92,144= $1,527,550
  • Mod P000102023-06-07-$187,083= $1,340,468
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2018-03-23+$369,453$369,453IGF::OT::IGF BLOOD PRODUCTS
Mod P00001· EXERCISE AN OPTION2019-02-20+$366,935$736,388BLOOD PRODUCTS FOR CENTRAL TEXAS
Mod P00002· FUNDING ONLY ACTION2019-08-09−$66,521$669,867BLOOD PRODUCTS FOR CENTRAL TEXAS
Mod P00003· EXERCISE AN OPTION2020-03-30+$390,553$1,060,420BLOOD PRODUCTS FOR CENTRAL TEXAS
Mod P00004· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2020-09-28−$88,518$971,902BLOOD PRODUCTS FOR CENTRAL TEXAS
Mod P00005· EXERCISE AN OPTION2021-01-25+$390,553$1,362,455BLOOD PRODUCTS FOR CENTRAL TEXAS
Mod P00006· FUNDING ONLY ACTION2021-10-01−$130,836$1,231,619BLOOD PRODUCTS FOR CENTRAL TEXAS
Mod P00007· EXERCISE AN OPTION2022-01-04+$390,553$1,622,172BLOOD PRODUCTS FOR CENTRAL TEXAS
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-01-26−$2,478$1,619,694BLOOD PRODUCTS FOR CENTRAL TEXAS
Mod P00009· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2022-09-22−$92,144$1,527,550BLOOD PRODUCTS FOR CENTRAL TEXAS
Mod P00010· OTHER ADMINISTRATIVE ACTION2023-06-07−$187,083$1,340,468BLOOD PRODUCTS FOR CENTRAL TEXAS

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI RFL7D3RDNTN3)

AwardOffice · PSC / listingNet obligationsFY
36C25726N0225257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$483,336FY2026
36C25726N0141257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$1,879,193FY2026
36C25725N0173257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$475,040FY2025
36C25725N0172257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$996,312FY2025
36C25724N0180257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$919,065FY2024
36C25724N0098257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$163,033FY2024

Other recipients under 6515 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25726P0775USVETSERV, LLC257-NETWORK CONTRACT OFFICE 17 (36C257)$27,829FY2026
36C25726P0770TRILLAMED LLC257-NETWORK CONTRACT OFFICE 17 (36C257)$276,891FY2026
36C25726N0510TRILLAMED LLC257-NETWORK CONTRACT OFFICE 17 (36C257)$133,475FY2026
36C25726P0800ASCEND RESIDENTIAL ELEVATORS LLC257-NETWORK CONTRACT OFFICE 17 (36C257)$15,800FY2026
36C25726N0515LOVELL GOVERNMENT SERVICES INC.257-NETWORK CONTRACT OFFICE 17 (36C257)$40,452FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25718C0088_3600_-NONE-_-NONE- · retrieved 2026-09-26.